CK1 drives platelet activation and thrombosis via RIPK3–MLKL signaling, sustaining mitochondrial integrity and energy metabolism. Its inhibition curbs thrombosis without affecting viability or primary hemostasis, offering a safe antithrombotic target.
- Vipin Singh
- Mohammad Ekhlak
- Debabrata Dash